🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

CHEPLAPHARM Arzneimittel GmbH — Licensed Medicines

74 medicines held by CHEPLAPHARM Arzneimittel GmbH on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 74 products held by CHEPLAPHARM Arzneimittel GmbH
MedicineActive substanceLicence holderStatus
Seroquel 100 mg film-coated tablets
PA2239/022/002
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel 25 mg film-coated tablets
PA2239/022/001
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel XR 150mg prolonged-release tablets
PA2239/022/006
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel XR 200mg prolonged-release tablets
PA2239/022/007
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel XR 300mg prolonged-release tablets
PA2239/022/008
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel XR 400mg prolonged-release tablets.
PA2239/022/009
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel XR 50 mg prolonged-release tablets
PA2239/022/005
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Tandemact
EU/1/06/366/005-16
Glimepiride, Pioglitazone CHEPLAPHARM Arzneimittel GmbH
Tandemact
EU/1/06/366/17-22
Glimepiride, Pioglitazone hydrochloride CHEPLAPHARM Arzneimittel GmbH
Valcyte 450 mg film-coated tablets
PA2239/023/001
Valganciclovir hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
Valcyte 50 mg/ml powder for oral solution
PA2239/023/002
Valganciclovir hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
VEPESID 100 mg capsule, soft
PA2239/006/002
Etoposide CHEPLAPHARM Arzneimittel GmbH Marketed
VEPESID 50 mg capsule, soft
PA2239/006/001
Etoposide CHEPLAPHARM Arzneimittel GmbH Marketed
Vesanoid 10 mg soft capsules
PA1868/001/001
Tretinoin Cheplapharm Arzneimittel GmbH Marketed
Visudyne 15 mg powder for solution for infusion
EU/1/00/140/001
Verteporfin CHEPLAPHARM Arzneimittel GmbH
Xeloda 150 mg film-coated tablets
EU/1/00/163/001
Capecitabine Cheplapharm Arzneimittel GmbH
Xeloda 500 mg film-coated tablets
EU/1/00/163/002
Capecitabine Cheplapharm Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/001
Orlistat Cheplapharm Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/002
Orlistat CHEPLAPHARM Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/003
Orlistat Cheplapharm Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/004
Orlistat Cheplapharm Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/005
Orlistat Cheplapharm Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/006
Orlistat Cheplapharm Arzneimittel GmbH
Zineryt 40 mg + 12 mg powder and solvent for cutaneous solution
PA2239/018/001
Erythromycin, Zinc acetate dihydrate CHEPLAPHARM Arzneimittel GmbH Marketed
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.